Kent Hawryluk Net Worth & Insider Trades
Kent Hawryluk - Director, Gemphire Therapeutics Inc
What is Kent Hawryluk's Net Worth?
The current estimated net worth of Gemphire Therapeutics Inc's Director, Kent Hawryluk, is estimated to be about $775.49K . Kent Hawryluk owns about 113,951 units of Gemphire Therapeutics Inc common stock. In the last 2 years at Gemphire Therapeutics Inc, Kent Hawryluk has sold an estimated value of $0 worth.
What is Kent Hawryluk's Past Insider Trading?
Kent Hawryluk's largest purchase order was 56,889 units , worth over $413.84K on August 12, 2016. In total, Kent Hawryluk has made about 4 transactions over 2 years of their time at Gemphire Therapeutics Inc. Kent Hawryluk usually trades in August, with the busiest year in 2016. The most recent transaction was a purchase order of 25,000 units , worth over $236.75K on March 14, 2017.
Kent Hawryluk
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Kent Hawryluk's' Mailing Address?
- Mailing address is 17199 N. Laurel Park Drive Suite 401 Livonia MI 48152 MI
What are Gemphire Therapeutics Inc's Past Insider Trades?
Gemphire Therapeutics Inc's most recent insider trade came on February 12, 2018 by Seth Reno who bought 14,286 units worth $100K . In the last 2 years, insiders at Gemphire Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in August, with the busiest year in 2016. The most active traders at the company are Phd Steven Gullans, President & CEO, Andy Sassine, Director, and Jeffrey Mathiesen, Chief Financial Officer .
Gemphire Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||